Metaphore Biotechnologies, founded by Flagship Pioneering in 2021, is a biotechnology company focused on designing novel therapeutics. They leverage a unique MIMIC™ platform that combines machine learning and molecular mimicry to make previously intractable drug targets accessible and unlock breakthroughs that outperform today's drugs. Their aim is to achieve maximum patient impact, initially targeting autoimmune and metabolic diseases, and cancer.
- Category
- Drug Discovery
- Stage
- Series A
- Employees
- 52
- HQ
- Cambridge, United States
- Founded
- 2021
- Funding
- $50M